ChemFeeds Site Navigation:
Journal Selection:
Search:

99) Somatic Mutations in Relapsed DLBCL (Clinical Cancer Research) Sunday May 1st 2016


100) White Adipose Tissue Inflammation and Breast Cancer (Clinical Cancer Research) Sunday May 1st 2016


101) PDE5 Enhances Breast Cancer Cell Invasive Potential (Clinical Cancer Research) Sunday May 1st 2016


102) Tumor Microenvironment Immune Type in Pan-Cancer (Clinical Cancer Research) Sunday May 1st 2016


103) Strategic PI3K Inhibition for ER+ Breast Cancer (Clinical Cancer Research) Sunday May 1st 2016


104) Identification of an Immunogenic Subset of Uveal Melanoma (Clinical Cancer Research) Sunday May 1st 2016


105) Immune Recognition of Driver Mutations in Lymphoma (Clinical Cancer Research) Sunday May 1st 2016


106) VCN-01 Antisarcoma Effect (Clinical Cancer Research) Sunday May 1st 2016


107) Effect of Polyfunctional Neu T Cells Is TNF{alpha}/IL17 Dependent (Clinical Cancer Research) Sunday May 1st 2016


108) Detection of CTCs by a Novel In Vivo Approach (Clinical Cancer Research) Sunday May 1st 2016


109) Pseudoprogression/Radionecrosis and Kinetic FET-PET (Clinical Cancer Research) Sunday May 1st 2016


110) Inherited Genetics and Exposure to Chemotherapy (Clinical Cancer Research) Sunday May 1st 2016


111) Heterogeneity of PD-L1 (Clinical Cancer Research) Sunday May 1st 2016


112) An Alternative for Patient-Derived Xenograft (Clinical Cancer Research) Sunday May 1st 2016


113) Myeloid DCs Induce Effective Responses in Melanoma Patients (Clinical Cancer Research) Sunday May 1st 2016


114) Evaluation of PF-03446962 in Patients with Solid Tumors (Clinical Cancer Research) Sunday May 1st 2016


115) Afatinib and Nimotuzumab in Non-Small Cell Lung Cancer (Clinical Cancer Research) Sunday May 1st 2016


116) Comparative Oncology in Drug Development (Clinical Cancer Research) Sunday May 1st 2016


117) Optimizing Doses and Schedules of Small Targeted Drugs (Clinical Cancer Research) Sunday May 1st 2016


118) ER Stress, Dendritic Cells, and Cancer Immunity (Clinical Cancer Research) Sunday May 1st 2016


119) Quantifying Treatment Benefit in Molecular Subgroups (Clinical Cancer Research) Sunday May 1st 2016


120) Most Expedited Safety Reports Are Uninformative (Clinical Cancer Research) Sunday May 1st 2016


121) Immunotherapy of Breast Cancer (Clinical Cancer Research) Sunday May 1st 2016


122) Biomarkers for PD-1 Axis Therapies (Clinical Cancer Research) Sunday May 1st 2016


123) Strategic Scheduling of PI3K Inhibitors (Clinical Cancer Research) Sunday May 1st 2016


124) NOTCH1-Driven Cancer Stem Cells in Adenoid Cystic Carcinoma (Clinical Cancer Research) Friday April 15th 2016


125) Implications of DNA Methylation for Renal Cell Cancer Risk (Clinical Cancer Research) Friday April 15th 2016


126) FA Loss Drives Tumor Cell Invasion (Clinical Cancer Research) Friday April 15th 2016


127) CML LSCs Express CD25 (Clinical Cancer Research) Friday April 15th 2016


128) ICR in CSCs Maintains ICAM-1 Expression in HCC (Clinical Cancer Research) Friday April 15th 2016


129) Intraclonal Diversification of IG Genes in SMZL (Clinical Cancer Research) Friday April 15th 2016


130) Romidepsin and Azacitidine Synergize in CTCL (Clinical Cancer Research) Friday April 15th 2016


131) Inhibition of PI3K{alpha} Radiosensitizes Head and Neck Tumors (Clinical Cancer Research) Friday April 15th 2016


132) Mechanism of Palbociclib-Induced Bone Marrow Suppression (Clinical Cancer Research) Friday April 15th 2016


133) ADC Cancer Therapeutic Targeting ENPP3 (Clinical Cancer Research) Friday April 15th 2016


134) Cytotoxicity of Ixazomib for NPMc+ AML (Clinical Cancer Research) Friday April 15th 2016


135) PD-L1 Is Highly Expressed in Primary Prostate Cancer (Clinical Cancer Research) Friday April 15th 2016


136) Stat3/5 Signaling Architecture in High-Risk MDS (Clinical Cancer Research) Friday April 15th 2016


137) Gemtuzumab Ozogamicin in Pediatric FLT3/ITD AML Patients (Clinical Cancer Research) Friday April 15th 2016


138) KDR Amplification in NSCLC (Clinical Cancer Research) Friday April 15th 2016


139) Phase 1 Study of Pan-Class PI3K Inhibitor GSK2126458 (Clinical Cancer Research) Friday April 15th 2016


140) Nelfinavir Combined with Radiotherapy for Rectal Cancer (Clinical Cancer Research) Friday April 15th 2016


141) NK Cell Therapy for Elderly AML Patients (Clinical Cancer Research) Friday April 15th 2016


142) Cancer Patient Tobacco Use Measurement (Clinical Cancer Research) Friday April 15th 2016


143) Dendritic Cell Vaccines (Clinical Cancer Research) Friday April 15th 2016


144) Targeting Cancer with Individualized Neoepitope Vaccines (Clinical Cancer Research) Friday April 15th 2016


145) Making Better CARs for Adoptive T-cell Therapy (Clinical Cancer Research) Friday April 15th 2016


146) Immune Monitoring for Cancer Immunotherapies (Clinical Cancer Research) Friday April 15th 2016


147) T-cell Exhaustion in Cancer (Clinical Cancer Research) Friday April 15th 2016


148) Opportunities and Challenges in Cancer Immunotherapy (Clinical Cancer Research) Friday April 15th 2016


149) Disruptive Immunology (Clinical Cancer Research) Friday April 15th 2016


150) Isocitrate Dehydrogenase Mutations in Cancer (Clinical Cancer Research) Friday April 15th 2016


151) Nelfinavir as a Clinical Radiosensitizer (Clinical Cancer Research) Friday April 15th 2016


152) NK Cell-Based Cancer Immunotherapy (Clinical Cancer Research) Friday April 15th 2016


153) Measuring Toxicity in Phase I Clinical Trials--Letter (Clinical Cancer Research) Friday April 1st 2016


154) Afatinib + Cetuximab First-line in EGFR-Mutant Lung Cancer--Letter (Clinical Cancer Research) Friday April 1st 2016


155) HER2 and HER3 in HPV+ and HPV- HNSCC--Response (Clinical Cancer Research) Friday April 1st 2016


156) HER2 and HER3 in HPV+ and HPV- HNSCC--Letter (Clinical Cancer Research) Friday April 1st 2016


157) Pericytes Promote Metastasis and Predict Relapse (Clinical Cancer Research) Friday April 1st 2016


158) Hepatitis Induces EMT in HCC by TNF{alpha}/NF-{kappa}B/Snail Activation (Clinical Cancer Research) Friday April 1st 2016


159) The Effect of Nicotine on c-Met in Pancreatic Cancer (Clinical Cancer Research) Friday April 1st 2016


160) High-Risk Prostate Cancer Prognostic Outlier Gene Landscape (Clinical Cancer Research) Friday April 1st 2016


161) InsR/IGF1R Confers Resistance to EGFR Inhibitors (Clinical Cancer Research) Friday April 1st 2016


162) Biomarker for Early Breast Cancer Detection (Clinical Cancer Research) Friday April 1st 2016


163) hnRNPH1-AR Axis in Prostate Tumorigenesis (Clinical Cancer Research) Friday April 1st 2016


164) Reduced Serum TSP-1 Prior to Clinical Diagnosis of PDAC (Clinical Cancer Research) Friday April 1st 2016


165) A 5-Marker Blood Test for CRC Early Detection (Clinical Cancer Research) Friday April 1st 2016


166) Chronic Stress and DUSP1-Mediated Chemoresistance (Clinical Cancer Research) Friday April 1st 2016


167) mTOR Inhibitors Impair HR Repair through Suppressing SUV39H1 (Clinical Cancer Research) Friday April 1st 2016


168) TH-302 Targets Hypoxic Cells in Leukemia Models (Clinical Cancer Research) Friday April 1st 2016


169) PLK1 Inhibition in NSCLC (Clinical Cancer Research) Friday April 1st 2016


170) Nuclear Export Inhibition and Radiation in Rectal Cancer (Clinical Cancer Research) Friday April 1st 2016


171) Multigene Signatures in TNBC (Clinical Cancer Research) Friday April 1st 2016


172) Mesothelin Imaging in Pancreatic or Ovarian Cancer Patients (Clinical Cancer Research) Friday April 1st 2016


173) Monitoring Treatment Response of m-IDH Glioma by 2HG-fSM (Clinical Cancer Research) Friday April 1st 2016


174) TOP1 as a Predictive Biomarker for Irinotecan (Clinical Cancer Research) Friday April 1st 2016


175) Plasma Circulating Proteins and Bevacizumab (Clinical Cancer Research) Friday April 1st 2016


176) Early Metabolic Response in Advanced Gastric Cancer (Clinical Cancer Research) Friday April 1st 2016


177) Personalized Therapies in BRAF Inhibitor-Resistant PDX (Clinical Cancer Research) Friday April 1st 2016


178) Phase I BKM120 (Buparlisib) and Fulvestrant in Breast Cancer (Clinical Cancer Research) Friday April 1st 2016


179) Ibrutinib Disrupts CLL Tumor-Microenvironment Interactions (Clinical Cancer Research) Friday April 1st 2016


180) TREC to Where? (Clinical Cancer Research) Friday April 1st 2016


181) Gene Therapy for Epithelial Cancers (Clinical Cancer Research) Friday April 1st 2016


182) Core Patient-Reported Outcomes in Cancer Clinical Trials (Clinical Cancer Research) Friday April 1st 2016


183) PDX System for Modeling Personalized Medicine (Clinical Cancer Research) Friday April 1st 2016


184) Ibrutinib Remodels the CLL Microenvironment (Clinical Cancer Research) Friday April 1st 2016


185) Flightless I Represses Androgen Receptor (Clinical Cancer Research) Monday March 14th 2016


186) Aggressive Variant Prostate Cancers Signature (Clinical Cancer Research) Monday March 14th 2016


187) CTCs in Neuroendocrine Prostate Cancer (Clinical Cancer Research) Monday March 14th 2016


188) MEK Inhibition Cooperates with Anti-PD-L1 Therapy in TNBC (Clinical Cancer Research) Monday March 14th 2016


189) Prognostic Molecular Factors in Colorectal Cancer by Age (Clinical Cancer Research) Monday March 14th 2016


190) CXCR4 Mutation in Waldenstrom Macroglobulinemia (Clinical Cancer Research) Monday March 14th 2016


191) Effects of Pharmacokinetic Modulation of Anti-DLL4 Antibody (Clinical Cancer Research) Monday March 14th 2016


192) Combined Photodynamic Therapy-Immunotherapy against Advanced Cancer (Clinical Cancer Research) Monday March 14th 2016


193) A Novel Bioavailable BH3 Mimetic (Clinical Cancer Research) Monday March 14th 2016


194) Inhibition of Pancreatic Cancer by RhIL1RA (Clinical Cancer Research) Monday March 14th 2016


195) ERR{alpha} Is a Marker of Tamoxifen Response in TNBC (Clinical Cancer Research) Monday March 14th 2016


196) Breast Cancer Risk Variants and Radiation Toxicity (Clinical Cancer Research) Monday March 14th 2016


View: prev | next


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()